![](/img/cover-not-exists.png)
P3.02b-044 Afatinib versus Gefitinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients Aged ≥75 Years: Subgroup Analysis of LUX-Lung 7
Park, Keunchil, Tan, Eng Huat, Zhang, Li, Hirsh, Vera, O'Byrne, Ken, Boyer, Michael, Chih-Hsin Yang, James, Mok, Tony, Peil, Barbara, Märten, Angela, Paz-Ares, LuisVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1711
Date:
January, 2017
File:
PDF, 138 KB
english, 2017